STOCK TITAN

GoodRx Holdings, Inc. - GDRX STOCK NEWS

Welcome to our dedicated page for GoodRx Holdings news (Ticker: GDRX), a resource for investors and traders seeking the latest updates and insights on GoodRx Holdings stock.

GoodRx Holdings, Inc. (Symbol: GDRX) is a leading consumer-focused digital healthcare platform committed to reducing the cost of healthcare in the United States. The company operates a price comparison platform that provides consumers with current, geographically relevant pricing for prescription medications. GoodRx gathers prices from multiple sources, offering powerful savings tips, valuable discounts, and negotiable price codes for prescriptions at virtually every pharmacy across the US.

GoodRx serves millions of Americans each month, including thousands of physicians who use the platform to help their patients. To date, the company has saved users over $3 billion on their prescription drug costs. Despite this success, GoodRx continues to work toward making prescriptions affordable for all Americans.

The company's core revenue stream comes from pharmacy benefit managers (PBMs), who manage formularies and prescription transactions. GoodRx also offers additional healthcare products and services such as pharma manufacturer solutions, subscription plans, and telehealth services. Their platform extends beyond individual consumers to include solutions for health plans, payors, and PBMs through an easy-to-use website and mobile app experience known as GoodRx for Benefits.

As GoodRx continues to innovate and expand its offerings, it remains dedicated to its mission of lowering healthcare costs and making essential medications accessible to everyone in the US. Stay updated with the latest news and developments from GoodRx to see how they are transforming the healthcare landscape.

Rhea-AI Summary

GoodRx (NASDAQ: GDRX) has announced an agreement to acquire vitaCare Prescription Services from TherapeuticsMD for $150 million, plus up to $7 million contingent on performance through 2023. The acquisition aims to enhance patient access and adherence to brand medications by addressing affordability and insurance communication barriers. GoodRx expects this transaction to contribute under 1% to overall revenue and reduce adjusted EBITDA margin by about 2% in 2022, while anticipates future growth in revenue and profitability.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.95%
Tags
-
Rhea-AI Summary

GoodRx Holdings has released its fourth quarter and full year 2021 financial results, highlighting its role as a leading digital healthcare platform. The company has saved consumers over $35 billion since its inception in 2011. A conference call to discuss these results is scheduled for today at 2:00 p.m. PT. Investors can access the live call and its archive on the GoodRx investor relations website.

GoodRx continues to grow as one of the most downloaded medical apps.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-38.91%
Tags
-
Rhea-AI Summary

GoodRx Holdings has announced a new share repurchase program authorized to buy back up to $250 million of its Class A Common Stock. The program aims to enhance shareholder value and reflects the company's confidence in its future growth. Repurchases will be executed based on market conditions, using existing cash and cash equivalents, with reports indicating $941.1 million in cash available as of December 31, 2021. The program is effective immediately and may be modified or terminated by the Board at their discretion before February 23, 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-38.91%
Tags
buyback
Rhea-AI Summary

GoodRx Holdings Inc. (NASDAQ: GDRX) announced its participation in key investor conferences in March. Executives will present at the Raymond James 43rd Annual Institutional Investors Conference in Orlando, FL, on March 8 at 7:25 a.m. PT; at the Cowen 42nd Annual Health Care Conference virtually on March 9 at 8:10 a.m. PT; and at the Deutsche Bank 30th Annual Media, Internet & Telecom Conference in Palm Beach, FL, on March 15 at 6:35 a.m. PT. Live webcasts and archived recordings will be accessible via their Investor Relations website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.99%
Tags
conferences
-
Rhea-AI Summary

GoodRx Holdings Inc. (NASDAQ: GDRX) will release its fourth quarter and full year 2021 financial results after U.S. markets close on February 28, 2022. A conference call will occur at 2:00 p.m. PT to discuss the results and future outlook. The financial results will be available on their investor relations website. GoodRx, a leading digital healthcare platform, has helped consumers save over $35 billion since 2011, establishing itself as a crucial resource for affordable healthcare.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.16%
Tags
-
Rhea-AI Summary

GoodRx Holdings, Inc. (Nasdaq: GDRX) will present at the virtual 40th Annual J.P. Morgan Healthcare Conference on Thursday, January 13, at 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time). A live webcast of the presentation will be accessible via the Company’s Investor Relations website, and an archived recording will be available for at least 30 days post-conference. Since its inception in 2011, GoodRx has helped Americans save over $35 billion, making healthcare more affordable and convenient.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.49%
Tags
conferences
Rhea-AI Summary

GoodRx Holdings Inc. (NASDAQ: GDRX) has announced participation in two upcoming investor conferences. The first is the Credit Suisse 25th Annual Technology Conference on December 1, 2021, at 1:20 p.m. PT in Scottsdale, AZ. The second is the Barclays Global Technology, Media and Telecommunications Conference on December 7, 2021, at 11:25 a.m. PT, held virtually. Live webcasts and presentation materials will be accessible on the Company's Investor Relations website, with archived recordings available for 30 days post-conference.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.87%
Tags
conferences
-
Rhea-AI Summary

GoodRx has released its State of Telehealth report, highlighting significant changes in telehealth usage due to the COVID-19 pandemic. Over 1,600 providers and patients were surveyed, revealing that 40% of consumers feel they interact more with providers via telehealth. Additionally, 70% of providers noted improved continuity of care. Post-pandemic, 60% of consumers plan to adopt a hybrid model of care. While 45% of providers reported higher no-show rates for telehealth appointments, overall satisfaction remains high, with GoodRx's telehealth service achieving a 92% satisfaction rate and saving consumers an estimated $243 million in medical costs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.03%
Tags
none
-
Rhea-AI Summary

GoodRx Holdings, Inc. (GDRX) announced its third quarter 2021 financial results, highlighting its role as a digital healthcare resource that has saved consumers $35 billion since inception in 2011. The company hosted a conference call on November 10, 2021, at 2:00 PM PT to discuss these results and its business outlook. GoodRx is recognized as one of the most downloaded medical apps, emphasizing its significant impact on healthcare affordability and access in the U.S.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.17%
Tags
Rhea-AI Summary

GoodRx Holdings Inc. (NASDAQ: GDRX) will release its third quarter 2021 financial results on November 10, 2021, after U.S. market close. A conference call will follow at 2:00 p.m. PT (5:00 p.m. ET), discussing the results and future business outlook. A press release with a link to a shareholder letter will be available on their investor relations website prior to the call. GoodRx, since its inception in 2011, has saved consumers over $30 billion in healthcare costs and remains a leading medical app in the U.S.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.11%
Tags

FAQ

What is the current stock price of GoodRx Holdings (GDRX)?

The current stock price of GoodRx Holdings (GDRX) is $4.9 as of November 22, 2024.

What is the market cap of GoodRx Holdings (GDRX)?

The market cap of GoodRx Holdings (GDRX) is approximately 1.8B.

What does GoodRx Holdings, Inc. do?

GoodRx Holdings, Inc. is a digital healthcare platform that helps reduce the cost of prescriptions by offering price comparisons, discounts, and savings tips for medications across the US.

How does GoodRx save money on prescriptions?

GoodRx collects and compares current prescription prices from various sources, providing users with discounts and negotiable price codes that can be used at nearly every pharmacy in the US.

Who benefits from using GoodRx?

Millions of Americans, including those with insurance or Medicare, benefit from using GoodRx to find affordable prescription prices. Physicians also use GoodRx to help their patients save money.

How much has GoodRx saved Americans so far?

GoodRx has saved Americans over $3 billion on their prescription drug costs.

What additional services does GoodRx offer?

Besides price comparison and discounts, GoodRx offers pharma manufacturer solutions, subscription plans, telehealth services, and GoodRx for Benefits, which provides solutions for health plans, payors, and PBMs.

How does GoodRx generate revenue?

GoodRx generates revenue primarily from pharmacy benefit managers (PBMs) who manage formularies and prescription transactions. The company also earns from its additional healthcare products and services.

What is GoodRx for Benefits?

GoodRx for Benefits is a technology solution that provides health plans, payors, and PBMs with an easy-to-use website and mobile app experience to manage and reduce healthcare costs.

Is GoodRx available as a mobile app?

Yes, GoodRx offers a mobile app that allows users to compare prescription prices, find discounts, and access savings tips on the go.

Why should I use GoodRx if I already have insurance?

Even with insurance or Medicare, prescription costs can be high. GoodRx helps you find lower prices and better discounts, making medications more affordable.

Where can I learn more about GoodRx?

Visit www.goodrx.com to learn more about how GoodRx can help you save on prescriptions and explore their additional healthcare services.

GoodRx Holdings, Inc.

Nasdaq:GDRX

GDRX Rankings

GDRX Stock Data

1.75B
88.30M
11.9%
70.75%
2.28%
Health Information Services
Services-computer Processing & Data Preparation
Link
United States of America
SANTA MONICA